ALLERGY NEW ENGLAND MIX
NDC 43406-0106, Betula Pubescens Bark, Artemisia Vulgaris Pollen, Plantago Lanceolata Pollen, Acer Pseudoplatanus Pollen, Betula Pubescens Bark, Evernia Prunastri Bark, Armaranthus Retroflexus Pollen, Pinus Massoniana Pollen, Tabuliformis Pollen, Ambrosia Artemisifolia Pollen,, liquid, from Natural Creations, Inc..
- Product NDC
- 43406-0106
- Status
- Listed
- Labeler
- Natural Creations, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43406-0106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BETULA PUBESCENS BARK6 [hp_X]/mL
- ARTEMISIA VULGARIS POLLEN6 [hp_X]/mL
- PLANTAGO LANCEOLATA POLLEN6 [hp_X]/mL
- ACER PSEUDOPLATANUS POLLEN6 [hp_X]/mL
- EVERNIA PRUNASTRI6 [hp_X]/mL
- AMARANTHUS RETROFLEXUS POLLEN6 [hp_X]/mL
- PINUS MASSONIANA POLLEN6 [hp_X]/mL
- PINUS TABULIFORMIS POLLEN6 [hp_X]/mL
- AMBROSIA ARTEMISIIFOLIA POLLEN6 [hp_X]/mL
- JUNIPERUS VIRGINIANA POLLEN6 [hp_X]/mL
- MORUS RUBRA POLLEN6 [hp_X]/mL
- RUMEX ACETOSELLA POLLEN6 [hp_X]/mL
- POPULUS ALBA POLLEN6 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Standardized Chemical Allergen [EPC]; Standardized Pollen Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43406-0106-1 | 43406010601 | 30 mL in 1 BOTTLE, SPRAY (43406-0106-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43406-0106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43406-0106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43406-0106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.